PYMNTS
AUGUST 9, 2020
A $765 million loan agreement between Eastman Kodak and the government to provide pharmaceutical ingredients has been put on hold due to questions about Kodak’s recent securities transactions. International Development Finance Corp. DFC) said it “will not proceed any further unless these allegations are cleared.”
PYMNTS
JANUARY 27, 2020
Ukraine’s financial watchdog has announced that it will monitor transactions that exceed $1,200, said Oksana Makarova, the head of the country’s Ministry of Finance, according to a Monday (Jan. million will go into the counterfeit tracking system for pharmaceuticals. 27) report by Coindesk. million), and into the healthcare system $18.6
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PYMNTS
JULY 29, 2020
Thus, in one fell swoop, the company is expanding facilities based in New York and Minnesota, creating a Kodak Pharmaceuticals operation. From 1988 to 1994, Kodak owned Sterling Winthrop, a pharmaceutical firm — which made drugs such as aspirin — before selling it to SmithKline Beecham in 1994 for $2.9 But it is not a path untried.
PYMNTS
AUGUST 10, 2020
Today’s Financial Times article states: “NMC allegedly used fake documents to simulate orders for pharmaceutical supplies from Neopharma, and its joint venture Nexgen, to obtain credit from banks and factoring agents that financed the fabricated sales.
Going Concern
JULY 8, 2022
to substantially shrink its tax burden and stash profits overseas to avoid paying taxes on prescription drug sales. to substantially shrink its tax burden and stash profits overseas to avoid paying taxes on prescription drug sales.
Withum
JUNE 6, 2022
Section 1202 provides for the full or partial exclusion of capital gain realized on the sale of QSBS. The taxpayer in PLR 202221006 (March 3, 2022) is a pharmaceutical distributor that engages in the retail sale of a limited number of drugs. The IRS noted that all of the taxpayer’s revenues are generated by the sale of drugs.
PYMNTS
JUNE 24, 2020
The retailer, along with Harbin Pharmaceutical Group Holding Co., and a sizable majority of supporting secured lenders, have come to a deal “in principle” for a sale of GNC’s business. A $760 million purchase price was noted in a term sheet outlining the arrangement, which would be put into place via court auction.
Expert insights. Personalized for you.
75 
Let's personalize your content